◑ We're currently building out coverage for Swiss-listed stocks (SIX Swiss Exchange). Other markets will follow.

Basilea Pharmaceutica AG

CH0011432447 · BSLNSIX ·

CH · Healthcare · Stock

Basilea Pharmaceutica AG is a Swiss biopharmaceutical company headquartered in Allschwil, near Basel, focused on developing and commercializing drugs to treat serious and life-threatening bacterial and fungal infections as well as oncology indications. Its key marketed products include the antifungal agent isavuconazole and the antibiotic ceftobiprole. The company was spun off from Roche in 2000 and is listed on the SIX Swiss Exchange.

Dividend Yield

5.31%

TTM · SIX

Last Dividend

5.00

CHF · 2013-04-11

5Y Growth

—

CAGR

Frequency

None

Years Paid

consecutive

Not Cut

—

consecutive yrs

Grown

—

consecutive yrs

Listings

Exchange	Ticker	Currency	Yield TTM
SIX primary	BSLN	CHF	5.31%

Total Return

Starting Amount 10'000 CHF

Price Gain −454 CHF

Dividends —

Total Return -4.54%

CAGR -4.54%

End Balance 9'546 CHF

Based on 10,000 invested at the start of the period. Price return uses split-adjusted closing prices. Dividends are not reinvested.

Annual Dividends

2013 CHF 5.00

2013

Annual dividend per share · 1 years of data

Dividend Yield History

Loading yield history…

ⓘ

Dividend History

Ex-Date ▼	Pay-Date ▼	Amount ▼	Type ▼
11.04.2013	21.06.2013	5.00 CHF	Ordinary